Orthobond received on April 5th de novo approval for the company’s spinal fusion device with quaternary ammonium compound coating. Orthobond’s antibacterial treatment, Ostaguard™, covalently bonds its antimicrobial,...more
EndoStim announced on October 25th that the FDA granted a breakthrough device designation for the company’s implantable neurostimulation treatment for drug refractory gastroesophageal reflux disease (GERD)....more
WEISNER v. GOOGLE LLC -
Before Stoll, Reyna, and Hughes, Appeal from the United States District Court for the Southern District of New York.
Summary: The specific implementation of an abstract idea, such as improving...more
The 3M Company announced on July 26th that it will spin off its health care business into a separate, publicly-traded company. The health care business will focus on wound care, oral care, healthcare IT, and biopharma...more
LG ELECTRONICS INC. v. IMMERVISION INC.
Before Stoll, Cunningham, and Newman, Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board.
Summary: Where a reference contains an “obvious”...more
7/13/2022
/ Appeals ,
Clerical Errors ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
LG Electronics ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
POSITA